Features | Partner Sites | Information | LinkXpress
Sign In
Ampronix
ElsMed
Schiller

MRI Identifies Early Breast Cancer in At-Risk Survivors of Childhood Hodgkin Lymphoma

By Medimaging International staff writers
Posted on 04 Jun 2014
Magnetic-resonance imaging (MRI) has been shown to identify invasive breast tumors at very early stages, when cure rates are expected to be excellent, according to recent findings of the largest clinical study ever done to evaluate breast cancer screening of female survivors of childhood Hodgkin lymphoma (HL). These patients are at increased risk because they received chest radiation.

The findings, published online May 28, 2014, in the American Cancer Society’s journal Cancer, emphasizes the need for at-risk childhood HL survivors and primary care physicians to be cognizant of established guidelines that advocate breast MRI screening from the age of 25 years or eight years after chest radiation (whichever is later), according to lead investigator Dr. David Hodgson, a radiation oncologist at Princess Margaret Cancer Center, University Health Network (UHN; Toronto, ON, Canada).

“Female survivors of childhood HL who had chest radiation should speak with their family doctor about after-care assessment and breast cancer screening,” remarked Dr. Hodgson. “We estimate that 75% of women who are at high risk because of prior radiotherapy to the chest are not being screened. So my hope is that this new evidence will encourage these survivors to discuss early screening with their physicians. There is a provincial pediatric oncology aftercare system already in place to help them, organized by the Pediatric Oncology Group of Ontario [POGO].”

Dr. Hodgson’s study colleagues, in collaboration with colleagues at the Dana Farber Cancer Institute (Boston, MA, USA), performed 274 breast MRI scans on 96 women from 2005 to 2012. Ten breast tumors—50% of them invasive cancers—were diagnosed in nine women during 363 person-years follow up. The median age of breast cancer diagnosis was 39 years (range 24 to 43 years), and the median latency time period between HL diagnosis and age at breast cancer diagnoses was 21 years (range 12 to 27 years). “This illustrates the young age at which these cancers can occur. For some of these women, if they had been screened starting at age 40 or 50 like average risk women, it would have been too late,” commented Dr. Hodgson.

Of the 10 identified breast tumors, five were seen on both MRI and mammogram; three were visible only on MRI; and two were detected on mammogram by itself (but were noninvasive). The median size of invasive tumors size was 8 mm (range 3–15 mm) and none had metastasized to the lymph nodes. These findings are considerably better than earlier studies using only mammographic screening in these young patients, in which almost half of the cancers identified had cancer spread to the lymph nodes.

Dr. Hodgson noted that because MRI screening is so much more sensitive to small alterations in the appearance of the breast tissue than mammography, up to one-third of patients may be called back for further testing of suspicious findings, many of which are benign or not clinically significant and therefore require no treatment. “It’s important to forewarn at-risk HL survivors because call backs definitely heighten anxiety.”

Related Links:

Princess Margaret Cancer Center
Dana Farber Cancer Institute



Channels

Radiography

view channel
Image: Whole body images of a mouse before and after nanoparticles injections. Signal loss in the liver and the spleen due to the accumulation of iron from the nanoparticles is indicated by the red arrows. (Photo courtesy of Imperial College London).

Self-Assembling Nanoparticles Could Improve Cancer Diagnosis

Innovative nanoparticles boost the effectiveness of magnetic resonance imaging (MRI) scanning by specifically seeking out receptors that are found in cancerous cells. Developed by researchers at Imperial... Read more

Ultrasound

view channel
Image: The Vivid T8 cardiovascular ultrasound system offers quantitative features such as stress echo and transesophageal echocardiography (TEE) capabilities (Photo courtesy of GE Healthcare).

Mobile, Cardiovascular Ultrasound Features Stress Echo and Transesophageal Echocardiography Capabilities

A 58.5-kg mobile cardiovascular ultrasound system features innovative quantitative features such as stress echo, and transesophageal echocardiography (TEE) capabilities, designed for healthcare providers... Read more

Nuclear medicine

view channel

Proton Therapy Has Better Outcome over IMRT for Advanced Head and Neck Cancers

Radiation oncologists compared the world’s literature on outcomes of proton beam therapy in the treatment of a range of advanced head and neck cancers of the skull base compared to intensity-modulated radiation therapy (IMRT) and found that proton beam therapy significantly improved disease-free survival and tumor control... Read more

General/Advanced Imaging

view channel
Image: Participant fitted with fNIRS headgear (Photo courtesy of University of Pittsburgh Schools of the Health Sciences).

Portable Optical Imaging Tool Designed for Concussion Evaluation

Researchers have demonstrated that a portable, low-cost optical imaging application is useful in evaluation of concussions. Two separate research projects, published recently, represent important steps... Read more

Imaging IT

view channel

Enterprise Imaging and Content Management Technology Collaboration Designed to Optimize the Electronic Health Record

A joint solution developed for the US market provides multi-media, electronic content management for electronic health records (EHRs). The system provides real-time access to a patient’s full medical history across the hospital enterprise, enhancing decision-making and healthcare while lowering costs. The integration... Read more

Industry News

view channel

Hosting and Distribution Collaboration Established to Provide Radiation Dose Monitoring

PHS Technologies Group, LLC (Scottsdale, AZ, USA), a unit of PACSHealth, LLC, and a developer of software that monitors patient exposure to ionizing radiation, reported that Dell Healthcare and Life Sciences (Round Rock, TX, USA) will become a marketing, distribution, and hosting partner for its DoseMonitor OnLine software.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.